Get the Stockscreener App
0.558
0.72%
0.004
Pre-market:
.57
0.012
+2.15%
Amarin Corp Adr stock is traded at $0.558, with a volume of 633.60K.
It is up +0.72% in the last 24 hours and up +19.13% over the past month.
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
See More
Previous Close:
$0.554
Open:
$0.554
24h Volume:
633.60K
Relative Volume:
0.44
Market Cap:
$229.53M
Revenue:
$306.91M
Net Income/Loss:
$-59.11M
P/E Ratio:
-3.72
EPS:
-0.15
Net Cash Flow:
$6.35M
1W Performance:
+1.12%
1M Performance:
+19.13%
6M Performance:
-28.46%
1Y Performance:
-48.81%
1-Day Range:
$0.5441
$0.564
1-Week Range:
$0.5058
$0.5645
52-Week Range:
$0.4303
$1.37
Amarin Corp Adr Stock (AMRN) Company Profile
Name
Amarin Corp Adr
Sector
Industry
Phone
353 1 6699 020
Address
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
Compare AMRN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMRN
Amarin Corp Adr
|
0.558 | 229.53M | 306.91M | -59.11M | 6.35M | -0.15 |
|
LLY
Lilly Eli Co
|
725.72 | 689.73B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
78.69 | 349.44B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
147.03 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
171.56 | 303.17B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
97.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-23 | Resumed | JP Morgan | Underweight |
| Oct-25-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-06-23 | Upgrade | Jefferies | Hold → Buy |
| May-06-22 | Downgrade | JP Morgan | Neutral → Underweight |
| May-05-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-05-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| May-04-22 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-12-21 | Downgrade | Goldman | Neutral → Sell |
| Sep-29-20 | Resumed | JP Morgan | Neutral |
| Aug-26-20 | Initiated | Piper Sandler | Overweight |
| May-05-20 | Initiated | Northland Capital | Outperform |
| Mar-31-20 | Downgrade | Goldman | Buy → Neutral |
| Mar-31-20 | Downgrade | Jefferies | Buy → Hold |
| Mar-31-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Mar-13-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-02-20 | Initiated | Cowen | Outperform |
| Feb-18-20 | Upgrade | Citigroup | Neutral → Buy |
| Jan-06-20 | Initiated | JP Morgan | Neutral |
| Dec-16-19 | Downgrade | Stifel | Buy → Hold |
| Nov-20-19 | Initiated | Oppenheimer | Underperform |
| Nov-18-19 | Downgrade | Citigroup | Buy → Neutral |
| Nov-15-19 | Reiterated | SVB Leerink | Outperform |
| Oct-31-19 | Initiated | Aegis Capital | Buy |
| Oct-15-19 | Initiated | Goldman | Neutral |
| Aug-14-19 | Initiated | SVB Leerink | Outperform |
| Jul-09-19 | Reiterated | Jefferies | Buy |
| Jun-17-19 | Initiated | ROTH Capital | Buy |
| Mar-22-19 | Initiated | Stifel | Buy |
View All
Amarin Corp Adr Stock (AMRN) Latest News
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading - MSN
Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com
Italy grants VAZKEPA reimbursement for heart risk - Investing.com
Amarin Corporation plc (ADR) : Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) - Marketscreener.com
Amarin appoints new chief financial officer - Investing.com
Amarin Appoints Peter Fishman Chief Financial Officer - GlobeNewswire Inc.
Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com
Amarin granted extension to meet Nasdaq listing standards - Investing.com
European Equities Traded in the US as American Depositary Rise in Monday Trading - MSN
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading - MSN
European Equities Traded in the US as American Depositary Move Higher in Monday Trading - MSN
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) - Yahoo Finance
Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
Amarin stock touches 52-week low at $0.55 amid market challenges - Investing.com
European Equities Traded in the US as American Depositary Receipts Close Bearish Week on High Note Friday - MSN
A Must-See Look at Amarin's Best- and Worst-Case Scenarios - AOL
Amarin's Q3 Earnings In Line, Revenues Fall Shy Of Estimates - Barchart
Earnings call: Amarin reports Q3 revenue dip amid U.S. generic competition - Investing.com
Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript - AOL
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - MSN
Amarin stock plunges to 52-week low of $0.56 amid market challenges - Investing.com India
European Equities Traded in the US as American Depositary Receipts Decline Tuesday - MSN
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
Amarin Corp ADR [AMRN] Investment Guide: What You Need to Know - Knox Daily
The growth track for Amarin Corp ADR (AMRN) has changed recently - SETE News
BofA Securities downgrades Agilon Health Inc (AGL) stock to an Underperform - Knox Daily
Amarin Corp ADR (AMRN) requires closer examination - US Post News
Investing in Amarin Corp ADR (AMRN): What You Must Know - Knox Daily
Take off with Amarin Corp ADR (AMRN): Get ready for trading - SETE News
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
Capital One Financial Corp.’s latest rating changes from various analysts - Knox Daily
Opthea expands leadership team amid clinical trials - Investing.com
AMRN Stock Sees Surge of Approximately 1.68% in Last Five Days - Knox Daily
Amarin Corp ADR (AMRN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Amarin Corp ADR’s results are impressive - US Post News
JP Morgan’s latest rating for AMRN stock - Knox Daily
Stocks of Amarin Corp ADR (AMRN) are poised to climb above their peers - SETE News
Amarin Corp ADR [AMRN] Shares Fall Approximately -30.97% Over the Year - Knox Daily
Hillenbrand Inc [HI] Shares Rise 3.10 % on Thursday - Knox Daily
Marathon Oil Corporation [MRO] Shares Fall -3.25 % on Thursday - Knox Daily
A company insider recently sold 320,691 shares of Glatfelter Corporation [GLT]. Should You Sale? - Knox Daily
Trading Day Review: Amarin Corp ADR (AMRN) Loses Momentum, Closing at 0.57 - The Dwinnex
Does Amarin Corp ADR (AMRN) offer a good opportunity for investors? - SETE News
Amarin Corp ADR (AMRN) stock analysis: A comprehensive overview - US Post News
Understanding the Risks of Investing in Amarin Corp ADR (AMRN) - Knox Daily
GPK’s President and CEO, DOSS MICHAEL P, sellss 164,443 shares. - Knox Daily
Amarin stock touches 52-week low at $0.57 amid challenges - Investing.com
Amarin Corp ADR [AMRN] President and CEO makes an insider purchase of 160,000 shares worth 0.1 million. - Knox Daily
GE Aerospace [GE] Shares Rise 1.42 % on Thursday - Knox Daily
Taking the lead: Amarin Corp ADR (AMRN) - SETE News
FITB Stock Sees Surge of Approximately 6.00% in Last Five Days - Knox Daily
Amarin Corp Adr Stock (AMRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):